Exposure Time-Dependent Bactericidal Activities of Amoxicillin Against Actinobacillus pleuropneumoniae; an In Vitro and In Vivo Pharmacodynamic Model

Journal of Veterinary Medicine Series B: Infectious Diseases and Veterinary Public Health

Volumn 50, Issue 9, 2003, Pages 436-442

  Tanigawa, M ^a   Sawada, T ^a  

^a NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMAL; ANIMAL DISEASE; ARTICLE; BACTERIAL INFECTION; DELAYED RELEASE FORMULATION; DRUG ADMINISTRATION; DRUG EFFECT; GERMFREE ANIMAL; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MICROBIOLOGICAL EXAMINATION; PATHOGENICITY; PNEUMONIA; SWINE; SWINE DISEASE; TIME;

ACTINOBACILLUS INFECTIONS; ACTINOBACILLUS PLEUROPNEUMONIAE; AMOXICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; DELAYED-ACTION PREPARATIONS; DRUG ADMINISTRATION SCHEDULE; INJECTIONS, INTRAMUSCULAR; MALE; MICROBIAL SENSITIVITY TESTS; PLEUROPNEUMONIA; SPECIFIC PATHOGEN-FREE ORGANISMS; SWINE; SWINE DISEASES; TIME FACTORS;

ACTINOBACILLUS; ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMALIA; BACTERIA (MICROORGANISMS); SUS SCROFA;

EID: 0344549646     PISSN: 09311793     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0931-1793.2003.00703.x     Document Type: Article

References (38)

1. Acred, P., P. A. Hunter, L. Mizen, and G. N. Rolinson, 1971: α-amino-ρ-hydroxybenzylpenicillin (BRL2333), a new broad-spectrum semisynthetic penicillin: in vivo evaluation. Antimicrob. Agents Chemother. 1, 416-422.
2. Agerso, H., and C. Friis, 1998: Penetration of amoxycillin to the respiratory tract tissues and secretions in Actinobacillus pleuropneumoiae infected pigs. Res. Vet. Sci. 64, 251-257.
3. Brogden, R. N., T. M. Speight, and G. S. Avey, 1975: Amoxycillin: a review of its antibacterial and pharmacokinetic properties and therapeutic use. Dugs 9, 88-140.
4. Committee for Revision of MIC Determination Method. 1981; Revision of minimal inhibitory concentration (MIC) determination method. Chemotherapy (Tokyo) 29, 76-79.
5. Craig, W. A., and S. C. Ebert, 1992: Continuous infusion of β-lactam antibiotics. Antimicrob. Agents Chemother. 36, 2577-2583.
6. Diarra, M. S., F. Malouin, and M. Jacques, 1999: Postantibiotic and physiological effects of tilmicosin, tylosin, and apramycin at sub-minimal and suprainhibitory concentrations on some swine and bovine respiratory tract pathogens. Int. J. Antimicrob. Agent 12, 229-237.
7. Drusano, G. L., 1988: Role of pharmacokinetics in the outcome of infection. Antimicrob. Agents Chemother. 32, 289-297.
8. Farzam, F., and B. J. Plotkin, 2001: Effects of sub-MICs of antibiotrics on the hydrophobicity and production of acidic polysaccharide by Vibrio vulnificus. Chemotherapy 47, 184-193.
9. Fedorka-Cray, P. J., W. C. Cray, Jr., J. T. Gray, S. A. Breisch, L. Hoffman, and G. A. Anderson, 1993: Actinobacillus (Haemophilus) pleuropneumoniae. Part 1. History, epidemiology, serotyping, and treatment. Compend. Contin. Educ. Pract. Vet. 15, 1447-1455.
10. Fenwick, B., and S. Henry, 1994: Porcine pleuropneumonia. J.A.V.M.A. 204, 1334-1340.
11. Friss, C., 2000: Role of pharmacokinetics and pharmacodynamics in the outcome of infection. Proc. Int. Pig Vet. Soc. 16th Congress 16, 82-84.
12. Gemmel, C. G., 1987: Changes in expression of bacterial surface antigens induced by antibiotics and their influence on host defences. Pathol. Biol. 35, 1377-1381.
13. Johnson, C. C., 1996: In vitro testing: correlations of bacterial susceptibility, body fluid levels, and effectiveness of antibacterial therapy. In: Lorian, V., (ed), Antibiotics in Laboratory Medicine 4th edn, pp. 813-834, Williams & Wilkins, Baltimore, Maryland, USA.
14. Kiorpes, A. L., L. R. Backstrom, M. T. Collins, and G. O. Kruse, 1989: Comparison of conventional and long-acting oxytetracyclines in prevention of induced Actinobacillus Haemophillus pleuropneumoniae infection of growing swine. Can. J. Vet. Res. 53, 400-404.
15. Kondo, F., and H. Kuroki, 2001: The effects of subminimal inhibitory concentrations of β-lactam antibiotics against Clostridium perfrigens. Microbios 105, 163-174.
16. Kondo, F., and S. Satoh, 1995: Effects of subminimal inhibitory concentrations of β-lactam antibiotics against R-prasmid-bearing bacteria. Chemotherapy 41, 125-133.
17. Kundrat, W., 1972: Quick 45-Minute method for the microbiological detection of inhibitors in animal products. Die. Fleischwirtschaft. Nr. 4, 485-487.
18. Lindecrona, R. H., C. Friis, and N. E. Jensen, 1999: The pharmacodynamic effect of amoxicillin and danofloxacin against Actinobacillus pleuropneumoniae in an in-vitro pharmacodynamic model. Res. Vet. Sci. 67, 93-97.
19. Lorian, V., 1985: Low concentaration of antibiotics. J. Antimicrob. Chemother. 15(Suppl. A), 15-26.
20. MacInnes, J. I., and S. Rosendal, 1988: Prevention and contorol of Actinobacillus (Haemophillus) pleuropneumoniae infection in swine: a review. Can. Vet. J. 29, 572-574.
21. Milatovic, D., 1983: Antibiotics and phagocytosis. Eur. J. Clin. Microbiol. 2, 414-425.
22. Odenholt, I., 2001: Pharmacodynamic effects of subinhibitory antibiotic concentrations. Int. J. Antimicrob. Agents 17, 1-8.
23. Odenholt, I., S. E. Holm, and O. Cars, 1990: Effects of supra-and sub-MIC benzylpenicillin concentrations on group A β-haemolytic streptococci during the postantibiotic phase in vivo. J. Antimicrob. Chemother. 26, 193-201.
24. Ono, Y., Y. Ueda, M. Baba, H. Nishiya, and O. Kunii, 1989: Influence of a sub-inhibitory concentration of antibiotics on opsono-phargocytic functions of Klebsiella pneumoniae by human phagocytes. Chemotherapy (Tokyo) 37, 1487-1491.
25. Raponi, G., N. Keller, B. P. Overbeek, M. K., Rozenberg-Arska, P. M. Van Kessel, and J. Verhoef, 1990: Enhanced phagocytosis of encapsulated Escherichia coli strains after exposure to sub-MIC of antibiotics is correlated to changes of the bacterial cell surface. Antimicrob. Agents Chemother. 34, 332-336.
26. Roosendaal, R., I. A. J. M. Bakker-Wouderberg, M. Van-Den Berghe-Van Raffe, and M. F. Michel, 1986: Continuous veresus inetrmittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic rats. Antimicrob. Agents Chemother. 30, 403-408.
27. Soriano, F., 1992: Optimal dosage of β-lactam antibiotics: time above the MIC and inoculum effect. J. Antimicrob. Chemother. 30, 566-569.
28. Sutherland, R., and G. N. Rolinson, 1971: α-Amino-ρ- hydroxybenzylpenicillin (BRL2333), a new broad-spectrum semisynthetic penicillin: in vitro evaluation. Antimicrob. Agents Chemother. 1, 411-415.
29. Tabata, K., K. Yamaoka, A. Kaibara, S. Suzuki, M. Teraoka, and T. Hata, 1999: Moment analysis program available on Microsoft Excell. Xenobio. Metabol. Dispos. 14, 286-293.
30. Thomas, E., E. Grandemange, P. Pommier, S. Wessel-Robert, and J. L. Davot, 2000: Field evaluation of efficacy and tolerance of a 2% marbofloxacin injectable solution for the treatment of respiratory disease in fatting pigs. Vet. Quart. 22, 131-135.
31. Tubbs, R. C., 1988: Managing the swine herd that's been infected with Haemophilus pleuropneumoniae. Vet. Med. February, 220-229.
32. Veenhuizen, M. F., and W. J. Underwood, 1998: Management of nursery pig health with respiratory feed antibiotics. Large Animal Practice MAY/JUNE, 33-37.
33. Vogelman, B. S., and W. A. Craig, 1985: Postantibiotic effects. J. Antimicrob. Chemother. 15 (Suppl. A), 37-46.
34. Vogelman, B., S. Gudmundsson, J. Leggett, J. Turnidge, S. Ebert, and W. A. Craig, 1988: Correlation of antimicrobial pharmacokinetic parameters with theraputic efficacy in an animal model. J. Infect. Dis. 158, 831-847.
35. Wallgren, P., T. Segall, A. P. Morner, and P. Gunnarsson, 1999: Experimental infection with Actinobacilluspleuropnewnoniae in pigs - I. Comparison of five different parenteral antibiotic treatments. J. Vet. Med. B. 46, 249-260.
36. White, C. A., and R. D. Toothaker, 1985: Influence of ampicillin elimination half-life on in-vitro bactericidal effect. J. Antimicrob. Chemother. 15 (Suppl. A.), 257-260.
37. Yeoman, G. H., 1977: Microbiology and bioavailability of amoxicillin. Vet. Med./Small. Anim. Clinic. Suppl., 720-738.
38. Zinner, S. H., M. N. Dudley, D. Gilbert, and M. Bassignani, 1988: Effect of dose and schedule on cefoperazone pharmacodynamics in an in vitro model of infection in a neutropenic host. Am. J. Med. 85(Suppl. 1A), 56-58.